Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04644289
Title WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (WoO)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AGO Research GmbH
Age Groups: adult
Covered Countries DEU

No variant requirements are available.